Literature DB >> 12586109

Current status of the molecular characterization of the ovarian cancer antigen CA125 and implications for its use in clinical screening.

Caroline Whitehouse1, Ellen Solomon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12586109     DOI： 10.1006/gyno.2002.6708

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN： 0090-8258            Impact factor:   5.482


× No keyword cloud information.
  16 in total

1.  Identification of serum biomarkers for ovarian cancer using MALDI-TOF-MS combined with magnetic beads.

Authors:  Shengjun Wu; Kai Xu; Guang Chen; Jun Zhang; Zhiwei Liu; Xinyou Xie
Journal:  Int J Clin Oncol       Date:  2011-06-03       Impact factor: 3.402

2.  Detection of autoantibodies to multiple tumor-associated antigens in the immunodiagnosis of ovarian cancer.

Authors:  Liuxia Li; Kaijuan Wang; Liping Dai; Peng Wang; Xuan-Xian Peng; Jian-Ying Zhang
Journal:  Mol Med Rep       Date:  2008 Jul-Aug       Impact factor: 2.952

3.  Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis.

Authors:  Jie-Feng Cui; Yin-Kun Liu; Hai-Jun Zhou; Xiao-Nan Kang; Cheng Huang; Yi-Feng He; Zhao-You Tang; Toshimasa Uemura
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

4.  The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.

Authors:  Christine C Johnson; Bruce Kessel; Thomas L Riley; Lawrence R Ragard; Craig R Williams; Jian-Lun Xu; Saundra S Buys
Journal:  Gynecol Oncol       Date:  2008-06-30       Impact factor: 5.482

5.  Chronic Medical Conditions and CA125 Levels among Women without Ovarian Cancer.

Authors:  Babatunde O Akinwunmi; Ana Babic; Allison F Vitonis; Daniel W Cramer; Linda Titus; Shelley S Tworoger; Kathryn L Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-09-20       Impact factor: 4.254

Review 6.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

7.  Searching for Potential Ovarian Cancer Biomarkers with Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.

Authors:  Feng Qiu; Hong-Ying Liu; Zhen-Nan Dong; Ying-Ji Feng; X-J Zhang; Ya-Ping Tian
Journal:  Am J Biomed Sci       Date:  2009-01-01

8.  Methodology and applications of disease biomarker identification in human serum.

Authors:  Ziad J Sahab; Suzan M Semaan; Qing-Xiang Amy Sang
Journal:  Biomark Insights       Date:  2007-02-14

9.  The identification of unique serum proteins of HIV-1 latently infected long-term non-progressor patients.

Authors:  Rachel Van Duyne; Irene Guendel; Kylene Kehn-Hall; Rebecca Easley; Zachary Klase; Chenglong Liu; Mary Young; Fatah Kashanchi
Journal:  AIDS Res Ther       Date:  2010-07-06       Impact factor: 2.250

10.  Multicolor in vivo targeted imaging to guide real-time surgery of HER2-positive micrometastases in a two-tumor coincident model of ovarian cancer.

Authors:  Michelle Longmire; Nobuyuki Kosaka; Mikako Ogawa; Peter L Choyke; Hisataka Kobayashi
Journal:  Cancer Sci       Date:  2009-03-16       Impact factor: 6.716
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.